Publications

Quarterly summary of recent safety communications

Prescriber Update 43(3): 45
September 2022

The table below is a summary of recent safety communications to health care professionals and consumers, published on the Medsafe website.

Date	Communication	Topic
29/08/2022	Monitoring	Update – Possible risk of vasculitis with vildagliptin products (Galvus, Galvumet)
25/08/2022	Monitoring	Abnormal uterine bleeding and oral anticoagulants (blood thinners)
27/07/2022	Consultation	Outcome of the consultation on the proposed warning and advisory statements relating to the harm of opioid abuse
13/07/2022	Alert	Medsafe is publishing a warning that the product Nhan Sam Tuyet Lien Truy Phong Hoan should not be consumed
11/07/2022	Consultation	Proposed warning and advisory statement for ocular decongestants used for eye redness and/or minor eye irritation
30/06/2022	Alert	Accuretic found to contain nitrosamines
27/07/2022	Consultation	Outcome of the consultation on the proposed warning and advisory statements relating to harm of long-term use and overuse of stimulant laxatives
20/06/2022	Dear Healthcare Professional Letter	Comirnaty – Presentations available in New Zealand (PDF, 2 pages, 813 KB)
09/06/2022	Dear Healthcare Professional Letter	Supply of Canadian-labelled Coversyl 2 mg, 4 mg and 8 mg perindopril erbumine tablets in New Zealand (PDF, 3 pages, 260 KB)
07/06/2022	Alert	Typographical error in Healgen Rapid COVID-19 Antigen Self-Test (RATs) patient instruction leaflet